A strong player in the Barcelona market, RocaJunyent handles nationally significant M&A, private equity investments and corporate reorganisations across a variety of sectors, with a special emphasis on TMT, financial services and insurance. Noted for its ‘great professionalism and legal knowledge’, the group possesses strong capabilities in venture capital matters, and is often called upon by companies of all sizes, including multinationals and family-owned businesses. Xavier Altirriba is the main point of contact for French corporations looking for assistance with their investments in Spain. Managing partner Joan Roca is also recommended for M&A and contractual mandates.
Testimonials
Collated independently by Legal 500 research team.
‘The Roca team has offered us personalised attention, availability and adaptability at all times. Transactions have always been carried out to the end, and they have always sought practical solutions.'
‘Great dedication of the team and ability to adapt to our needs.’
‘Great professionalism and legal knowledge.’
‘ We consider that their professionalism and interpretation of client needs are well above the average of other firms.’
‘A solid, dedicated, highly qualified team. They anticipate the client's needs, which is why working with this team gives a lot of peace of mind.'
‘They know their client very well, they anticipate needs, they provide complete peace of mind.'
‘The internal coordination and the ability to work between teams makes this law firm a solid asset and makes it unique and leading.’
‘Francesc Baygual shows commitment, seriousness and reliability above expectations.'
Key clients
- 2m Holdings Limited
- Indukern, S.A.U. (now Vidara Life Ingredients, S.A.U.)
- Palex Medical, S.A.U.
- Ersm Insurance Brokers Correduria De Seguros Y Reaseguros, S.A
- Xta (Xarxes De Telecomunicacions Alternatives S.L.)
- Adam Foods
- Consorcio De La Zona Franca De Barcelona
- Global Social Impact
- Arthex Biotech
Work highlights
- Advised Arthex Biotech on a €42m financing round.
- Advised Indukern on the acquisitions of Promic, Galenicum Special Ingredients and Galenicum Special Ingredients Complementos Alimenticios España.
- Advised XTA on the sale of the company to Teras Capital Investments Holding for €25m.
Practice head
The lawyer(s) leading their teams.
Xavier Altirriba